CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-08 | Pay Paul William Director | Grant or award | +2,436 | $4.11 | $10K | 2,436 |
| 2020-01-08 | Pay Paul William Director | Grant or award · Common Share Warrants (Right to Buy) | +1,827 | 1,827 | ||
| 2020-01-08 | Pay Paul William Director | Grant or award · Common Share Warrants (Right to Buy) | +1,218 | 1,218 | ||
| 2020-01-08 | van der Velden Peter Director | Purchase | +128,722 | $3.20 | $412K | 1,833,066 |
| 2020-01-08 | van der Velden Peter Director | Purchase | +11,903 | $3.20 | $38K | 169,502 |
| 2020-01-08 | van der Velden Peter Director | Purchase · Common Share Warrants (Right to Buy) | +96,542 | 96,542 | ||
| 2020-01-08 | van der Velden Peter Director | Purchase · Common Share Warrants (Right to Buy) | +8,928 | 8,928 | ||
| 2020-01-08 | van der Velden Peter Director | Purchase · Common Share Warrants (Right to Buy) | +64,362 | 64,362 | ||
| 2020-01-08 | van der Velden Peter Director | Purchase · Common Share Warrants (Right to Buy) | +5,952 | 5,952 | ||
| 2020-01-08 | Sistilli Carlo Director | Purchase | +2,436 | $4.11 | $10K | 2,436 |
| 2020-01-08 | Sistilli Carlo Director | Purchase · Common Share Warrants (Right to Buy) | +1,827 | 1,827 | ||
| 2020-01-08 | Sistilli Carlo Director | Purchase · Common Share Warrants (Right to Buy) | +1,218 | 1,218 | ||
| 2020-01-08 | JOHNSON LORIN K Director | Purchase | +8,524 | $4.11 | $35K | 8,524 |
| 2020-01-08 | JOHNSON LORIN K Director | Purchase · Common Share Warrants (Right to Buy) | +6,393 | 6,393 | ||
| 2020-01-08 | JOHNSON LORIN K Director | Purchase · Common Share Warrants (Right to Buy) | +4,262 | 4,262 | ||
| 2020-01-08 | Brooks Michael J President | Purchase | +1,827 | $4.11 | $8K | 1,827 |
| 2020-01-08 | Brooks Michael J President | Purchase · Common Share Warrants (Right to Buy) | +1,371 | 1,371 | ||
| 2020-01-08 | Brooks Michael J President | Purchase · Common Share Warrants (Right to Buy) | +914 | 914 | ||
| 2019-09-11 | OAKES FRANK R. Director | Sale | −1,809 | $5.72 | $10K | 6,165 |
| 2019-07-26 | Brooks Michael J President | Grant or award · Stock Option (right to buy) | +7,663 | 136,416 |
Page 12 of 15 · 284 trades